Methods for modulating bone mineralization
US7192583B2 · kind B2 · utility
56Cited by
8References
5Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Mar 6, 2003 |
| Grant date | Mar 20, 2007 |
| Priority date | — |
| Expiry date | May 19, 2023 |
Classification
- Technology area (CPC G)Physics
- CPC primaryG01N2500/20
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
Antibodies to a novel family of TGF-β binding proteins are disclosed, for use in methods of altering bone density and bone mineralization, which methods are applicable to the treatment of diseases including osteopenia and osteoporosis.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.